THERAPEUTIC AGENT FOR HEPATOCELLULAR CARCINOMA

PROBLEM TO BE SOLVED: To provide a novel anticancer agent and therapeutic method having an excellent anticancer activity for hepatocellular carcinoma.SOLUTION: A therapeutic agent for hepatocellular carcinoma containing miriplatin and another therapeutic agent for hepatocellular carcinoma has a more...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: HANADA MITSUHARU, NAGASAKI HIROTOSHI
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:PROBLEM TO BE SOLVED: To provide a novel anticancer agent and therapeutic method having an excellent anticancer activity for hepatocellular carcinoma.SOLUTION: A therapeutic agent for hepatocellular carcinoma containing miriplatin and another therapeutic agent for hepatocellular carcinoma has a more excellent anticancer activity by applying transcatherter arterial chemo-embolization (TACE) with respect to hepatocellular carcinoma. As another therapeutic agent for hepatocellular carcinoma, doxorubicin hydrochloride, epirubicin hydrochloride, mitomycin C, or 5-fluorouracil is preferable, with mitomycin C being the most preferable. Further, formation of platinum-DNA crosslinking with miriplatin can be promoted by a combined use of another therapeutic agent for hepatocellular carcinoma.